Moderna says its COVID-19 vaccine has shown 94.5% efficiency based on initial Phase-3 trial data

The development of vaccines seems to have been picking up some pace…

Covid-19 Vaccine Update: Oxford vaccine elicits immune response, India’s Bharat Biotech to start phase 3 trials

The experimental Covid-19 vaccine being developed by the University of Oxford produces…